secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2025-02-07T23:59:59+00:00
Accession:  0000950170-25-016390
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics receives Nasdaq delisting notice for bid price and MVPHS noncompliance
--------------------------------------------------------------------------------

- Failed to regain compliance with minimum bid price ($1.00) by Feb 3, 2025 and MVPHS ($15M) by Feb 4, 2025.
- Nasdaq Staff notified company on Feb 5, 2025 that securities are subject to delisting unless hearing requested.
- Company plans to request hearing before Nasdaq Hearing Panel; will present plan to evidence compliance.
- Previously disclosed noncompliance with MVLS Rule; hearing request stays delisting action pending panel decision.
- No assurance that Panel will grant continued listing or that compliance can be achieved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025016390/0000950170-25-016390-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025016390/hcwb-20250205.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-016390

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer